ArticleSaudi journal of biological sciences2021
Pharmacological properties of biogenically synthesized silver nanoparticles using endophyte
Article in Saudi journal of biological sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- Microbial Synthesis of Precious Metal Nanoparticles and Their Applications: A Review.Microorganisms · 2026Review
- Genome-guided antimicrobial potential of Bacillus stercoris from coastal sand with activity against multidrug-resistant bacteria, including MRSA.International microbiology : the official journal of the Spanish Society for Microbiology · 2026Article
- Virulence potential of Bacillus cereus sensu lato group bacteria isolated from green leafy vegetables.Folia microbiologica · 2026Article
- Article
- Advancements in Green Synthesis of Silver-Based Nanoparticles: Antimicrobial and Antifungal Properties in Various Films.Nanomaterials (Basel, Switzerland) · 2025Review
- Antibacterial Potential of Biosynthesized Silver Nanoparticles UsingIndian journal of microbiology · 2024Article
- Optimization of subtilisin production fromSaudi journal of biological sciences · 2023Article
- Morphological modification of silver nanoparticles against multi-drug resistant gram-negative bacteria and cytotoxicity effect in A549 lung cancer cells through in vitro approaches.Archives of microbiology · 2023Article
- Antifungal Activity of Biosynthesized Silver Nanoparticles (AgNPs) againstJournal of functional biomaterials · 2022Article
- Green Extracellular Synthesis of Silver Nanoparticles byMolecules (Basel, Switzerland) · 2022Article
- Bioprospecting of endophytic actinobacterium associated with Aloe ferox mill for antibacterial activity.BMC complementary medicine and therapies · 2022Article
- Green Synthesized Silver Nanoparticles Using Lactobacillus Acidophilus as an Antioxidant, Antimicrobial, and Antibiofilm Agent Against Multi-drug Resistant Enteroaggregative Escherichia Coli.Probiotics and antimicrobial proteins · 2022Article
- Therapeutic Potential of Selected Medicinal Plant Extracts against Multi-Drug ResistantSaudi journal of biological sciences · 2022Article
- Vancomycin as an Antibacterial Agent Capped with Silver Nanoparticles: An Experimental Potential Analysis.BioMed research international · 2022Article
- Biogenic silver nanoparticles as antifungal agents.Frontiers in chemistry · 2022Review
- Biogenic Silver Nanoparticles: What We Know and What Do We Need to Know?Nanomaterials (Basel, Switzerland) · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The emergence of multidrug resistance in pathogenic bacteria limits the utilization of available antibiotics. The development of alternate options to treat infectious diseases is the need of the day.The present study was aimed to synthesize, characterize and evaluate the bioactive properties of silver nanoparticles. Endophytic bacterium
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.